Coronavirus Updates in The U.S., Europe & Asia

 

Pfizer Inc.’s Covid-19 vaccine has been approved by the United States of America for emergency use. This brings some hope and cheer. However, the number of Americans to be vaccinated to reach herd immunity is high and will take several months.

The U.S. has also doubled its order of Moderna’s vaccine. Modena is planning to ship vaccines to Europe this month. However, it will not be distributed till the company gets it approved.

Unfortunately, U.S. deaths and infections are setting a daily high. U.S. is heading towards dismal figure of 300,000 deaths. This time around New York surge is less deadly but still deep.

Wearing masks and social distancing is still particularly important as the pandemic will slow down with vaccinations, but vaccination will need to continue up to mid next year for a new normal.

Some of the other highlights around the world are as follows:

  • Germany’s infections and deaths have retreated after a Friday high
  • South Korea may add more social distancing measures
  • Bars and restaurants in Tokyo may have limited opening hours
  • Iran recorded its lowest infections in six weeks
  • Global cases exceed 71 million with over 1.59 million deaths
  • Swedish ICU’s are short staffed as frontline COVID-19 health workers quit posts.
  • Vaccines are currently the best hope to end the pandemic, but no timeline is available as yet

Source Bloomberg

Image by Angelo Esslinger from Pixabay

Chinese Aviation Authorities Recommend Diapers for Flight Attendants in A Bid to Contain Coronavirus in Airplane Toilets.


Follow us on Google news for more updates and News










Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.


CWEB.com is not registered as an investment adviser with the U.S. Securities and Exchange Commission. Rather, CWEB.com relies upon the “publisher’s exclusion” from the definition of investment adviser as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

Full Disclaimer